Literature DB >> 4941523

The management of polycythaemia vera.

L R Wasserman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4941523     DOI: 10.1111/j.1365-2141.1971.tb02698.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Determination of accuracy of polycythemia vera diagnoses and use of the JAK2V617F test in the diagnostic scheme.

Authors:  Paul Roda; Ashley Ferrari; Xiaoqin Tang; Porat Erlich; Cindy Eisenhower; Megha D Patel; Elizabeth Ann Irvin-Barnwell
Journal:  Ann Hematol       Date:  2014-04-01       Impact factor: 3.673

2.  Multiple paraneoplastic syndromes.

Authors:  A F Broomhead; J V Bertouch; P R Lam-Po-Tang
Journal:  J R Soc Med       Date:  1986-01       Impact factor: 5.344

Review 3.  Polycythemia Vera.

Authors:  Jerry L Spivak
Journal:  Curr Treat Options Oncol       Date:  2018-03-07

Review 4.  A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).

Authors:  Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

5.  Polycythemia as the first manifestation of Cushing's disease.

Authors:  A Gursoy; A Dogruk Unal; S Ayturk; S Karakus; A Nur Izol; N Bascil Tutuncu; N Guvener Demirag
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

6.  Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.

Authors:  J Eid; R F Ebert; M S Gesell; J L Spivak
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

Review 7.  Radionuclide therapy revisited.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1991

8.  Two clinical phenotypes in polycythemia vera.

Authors:  Jerry L Spivak; Michael Considine; Donna M Williams; Conover C Talbot; Ophelia Rogers; Alison R Moliterno; Chunfa Jie; Michael F Ochs
Journal:  N Engl J Med       Date:  2014-08-28       Impact factor: 91.245

9.  The effect of interleukin-4 with or without mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in healthy controls and in myeloproliferative disorders.

Authors:  T Siitonen; A Zheng; E R Savolainen; P Koistinen
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

10.  Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).

Authors: 
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.